Sripal Bangalore1, Yu Guo2, Zaza Samadashvili3, Saul Blecker2, Jinfeng Xu2, Edward L Hannan3. 1. New York University School of Medicine, New York, New York. Electronic address: sripalbangalore@gmail.com. 2. New York University School of Medicine, New York, New York. 3. School of Public Health, State University of New York at Albany, Albany, New York.
Abstract
BACKGROUND: Randomized trials of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) routinely exclude patients with chronic kidney disease (CKD). OBJECTIVES: This study evaluated outcomes of PCI versus CABG in patients with CKD. METHODS: Patients with CKD who underwent PCI using everolimus-eluting stents were propensity-score matched to patients who underwent isolated CABG for multivessel coronary disease in New York. The primary outcome was all-cause mortality. Secondary outcomes were myocardial infarction (MI), stroke, and repeat revascularization. RESULTS: Of 11,305 patients with CKD, 5,920 patients were propensity-score matched. In the short term, PCI was associated with a lower risk of death (hazard ratio [HR]: 0.55; 95% confidence interval [CI]: 0.35 to 0.87), stroke (HR: 0.22; 95% CI: 0.12 to 0.42), and repeat revascularization (HR: 0.48; 95% CI: 0.23 to 0.98) compared with CABG. In the longer term, PCI was associated with a similar risk of death (HR: 1.07; 95% CI: 0.92 to 1.24), higher risk of MI (HR: 1.76; 95% CI: 1.40 to 2.23), a lower risk of stroke (HR: 0.56; 95% CI: 0.41 to 0.76), and a higher risk of repeat revascularization (HR: 2.42; 95% CI: 2.05 to 2.85). In the subgroup with complete revascularization with PCI, the increased risk of MI was no longer statistically significant (HR: 1.18; 95% CI: 0.67 to 2.09). In the 243 matched pairs of patients with end-stage renal disease on hemodialysis, PCI was associated with significantly higher risk of death (HR: 2.02; 95% CI: 1.40 to 2.93) and repeat revascularization (HR: 2.44; 95% CI: 1.50 to 3.96) compared with CABG. CONCLUSIONS: In patients with CKD, CABG is associated with higher short-term risk of death, stroke, and repeat revascularization, whereas PCI with everolimus-eluting stents is associated with a higher long-term risk of repeat revascularization and perhaps MI, with no long-term mortality difference. In the subgroup on dialysis, the results favored CABG over PCI.
BACKGROUND: Randomized trials of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) routinely exclude patients with chronic kidney disease (CKD). OBJECTIVES: This study evaluated outcomes of PCI versus CABG in patients with CKD. METHODS:Patients with CKD who underwent PCI using everolimus-eluting stents were propensity-score matched to patients who underwent isolated CABG for multivessel coronary disease in New York. The primary outcome was all-cause mortality. Secondary outcomes were myocardial infarction (MI), stroke, and repeat revascularization. RESULTS: Of 11,305 patients with CKD, 5,920 patients were propensity-score matched. In the short term, PCI was associated with a lower risk of death (hazard ratio [HR]: 0.55; 95% confidence interval [CI]: 0.35 to 0.87), stroke (HR: 0.22; 95% CI: 0.12 to 0.42), and repeat revascularization (HR: 0.48; 95% CI: 0.23 to 0.98) compared with CABG. In the longer term, PCI was associated with a similar risk of death (HR: 1.07; 95% CI: 0.92 to 1.24), higher risk of MI (HR: 1.76; 95% CI: 1.40 to 2.23), a lower risk of stroke (HR: 0.56; 95% CI: 0.41 to 0.76), and a higher risk of repeat revascularization (HR: 2.42; 95% CI: 2.05 to 2.85). In the subgroup with complete revascularization with PCI, the increased risk of MI was no longer statistically significant (HR: 1.18; 95% CI: 0.67 to 2.09). In the 243 matched pairs of patients with end-stage renal disease on hemodialysis, PCI was associated with significantly higher risk of death (HR: 2.02; 95% CI: 1.40 to 2.93) and repeat revascularization (HR: 2.44; 95% CI: 1.50 to 3.96) compared with CABG. CONCLUSIONS: In patients with CKD, CABG is associated with higher short-term risk of death, stroke, and repeat revascularization, whereas PCI with everolimus-eluting stents is associated with a higher long-term risk of repeat revascularization and perhaps MI, with no long-term mortality difference. In the subgroup on dialysis, the results favored CABG over PCI.
Authors: S T Normand; M B Landrum; E Guadagnoli; J Z Ayanian; T J Ryan; P D Cleary; B J McNeil Journal: J Clin Epidemiol Date: 2001-04 Impact factor: 6.437
Authors: Sripal Bangalore; Helen A Vlachos; Faith Selzer; Robert L Wilensky; Kevin E Kip; David O Williams; David P Faxon Journal: Catheter Cardiovasc Interv Date: 2011-01-01 Impact factor: 2.692
Authors: William Chan; Joan Ivanov; Dennis Ko; Stephen Fremes; Vivek Rao; Sanjit Jolly; Warren J Cantor; Shahar Lavi; Christopher B Overgaard; Marc Ruel; Jack V Tu; Vladimír Džavík Journal: Circ Cardiovasc Interv Date: 2015-01 Impact factor: 6.546
Authors: George D Dangas; Patrick W Serruys; Dean J Kereiakes; James Hermiller; Ali Rizvi; William Newman; Krishnankutty Sudhir; Robert S Smith; Sherry Cao; Kleanthis Theodoropoulos; Donald E Cutlip; Alexandra J Lansky; Gregg W Stone Journal: JACC Cardiovasc Interv Date: 2013-09 Impact factor: 11.195
Authors: R R Azar; R Prpic; K K Ho; F J Kiernan; S J Shubrooks; D S Baim; J J Popma; R E Kuntz; D J Cohen Journal: Am J Cardiol Date: 2000-09-01 Impact factor: 2.778
Authors: Ali Ahmed; Ahsan Husain; Thomas E Love; Giovanni Gambassi; Louis J Dell'Italia; Gary S Francis; Mihai Gheorghiade; Richard M Allman; Sreelatha Meleth; Robert C Bourge Journal: Eur Heart J Date: 2006-05-18 Impact factor: 29.983
Authors: Donal N Reddan; Lynda Anne Szczech; Robert H Tuttle; Linda K Shaw; Robert H Jones; Steve J Schwab; Mark Stafford Smith; Robert M Califf; Daniel B Mark; William F Owen Journal: J Am Soc Nephrol Date: 2003-09 Impact factor: 10.121
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Abduzhappar Gaipov; Miklos Z Molnar; Praveen K Potukuchi; Keiichi Sumida; Robert B Canada; Oguz Akbilgic; Kairat Kabulbayev; Zoltan Szabo; Santhosh K G Koshy; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: J Thorac Cardiovasc Surg Date: 2018-09-27 Impact factor: 5.209
Authors: Lisheng Zhang; Jiao-Hui Wu; James C Otto; Susan B Gurley; Elizabeth R Hauser; Sudha K Shenoy; Karim Nagi; Leigh Brian; Virginia Wertman; Natalie Mattocks; Jeffrey H Lawson; Neil J Freedman Journal: Cardiovasc Res Date: 2017-11-01 Impact factor: 10.787
Authors: Felix Mahfoud; Ahmed Farah; Marc-Alexander Ohlow; Norman Mangner; Jochen Wöhrle; Sven Möbius-Winkler; Daniel Weilenmann; Gregor Leibundgut; Florim Cuculi; Nicole Gilgen; Christoph Kaiser; Marco Cattaneo; Bruno Scheller; Raban V Jeger Journal: Clin Res Cardiol Date: 2022-02-27 Impact factor: 6.138
Authors: Cristina Palacios; Cynthia M Pérez; Lorena González-Sepúlveda; Leonor Corsino; Sandra S Albrecht; Anna Maria Siega-Riz; Ramon A Durazo-Arvizu; Sarah Casagrande; Daniela Sotres-Alvarez; M Larissa Avilés-Santa Journal: J Am Nutr Assoc Date: 2020-11-30
Authors: Martin Möckel; Julia Searle; Henning Thomas Baberg; Peter Dirschedl; Benny Levenson; Jürgen Malzahn; Thomas Mansky; Christian Günster; Elke Jeschke Journal: Open Heart Date: 2016-10-03